Literature DB >> 11093165

The T cell activation molecule H4 and the CD28-like molecule ICOS are identical.

D Buonfiglio1, M Bragardo, V Redoglia, R Vaschetto, F Bottarel, S Bonissoni, T Bensi, C Mezzatesta, C A Janeway, U Dianzani.   

Abstract

The recently cloned CD28-like molecule ICOS displays striking similarities with H4, characterized some years ago in the mouse and recently in humans. Both molecules are selectively expressed by activated and germinal center T cells, display similar structure, and display co-stimulatory activities. H4 displays lateral association with the CD3/TCR and is expressed by mature thymocytes. In the mouse, H4 is also expressed at high levels by thymic NKT cells that are resistant to negative selection. The aim of this work was to evaluate whether H4 and ICOS are the same molecule using the C398.4A (binding human and mouse H4) and F44 (binding human ICOS) monoclonal antibody (mAb) in parallel experiments on human T cells. ICOS and H4 displayed the same expression pattern in a panel of T cell lines and the same expression kinetics in phytohemagglutinin-activated T cells. C398.4A completely blocked cell staining by F44, whereas F44 partially blocked C398.4A. H4 and ICOS immunoprecipitates displayed identical SDS-PAGE patterns and H4 immunoprecipitation completely removed ICOS from cell lysates. Finally, the C398.4A mAb specifically stained cells transfected with the human or mouse ICOS. These data prove that H4 and ICOS are the same molecule and that F44 and C398.4A bind partially different epitopes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093165     DOI: 10.1002/1521-4141(2000012)30:12<3463::AID-IMMU3463>3.0.CO;2-5

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation.

Authors:  Vanessa M Hubbard; Jeffrey M Eng; Teresa Ramirez-Montagut; Kartono H Tjoe; Stephanie J Muriglan; Adam A Kochman; Theis H Terwey; Lucy M Willis; Rafaella Schiro; Glen Heller; George F Murphy; Chen Liu; Onder Alpdogan; Marcel R M van den Brink
Journal:  Blood       Date:  2005-06-14       Impact factor: 22.113

2.  Inducible costimulator is essential for collagen-induced arthritis.

Authors:  Roza I Nurieva; Piper Treuting; Julie Duong; Richard A Flavell; Chen Dong
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

3.  Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults.

Authors:  Ramin Sedaghat Herati; Morgan A Reuter; Douglas V Dolfi; Kathleen D Mansfield; Htin Aung; Osama Z Badwan; Raj K Kurupati; Senthil Kannan; Hildegund Ertl; Kenneth E Schmader; Michael R Betts; David H Canaday; E John Wherry
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

4.  ICOS costimulation expands Th2 immunity by augmenting migration of lymphocytes to draining lymph nodes.

Authors:  Amanda G Tesciuba; Rebecca A Shilling; Monica D Agarwal; Hozefa S Bandukwala; Bryan S Clay; Tamson V Moore; Joel V Weinstock; Andrew A Welcher; Anne I Sperling
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

5.  Ligand binding sites of inducible costimulator and high avidity mutants with improved function.

Authors:  Shengdian Wang; Gefeng Zhu; Koji Tamada; Lieping Chen; Jürgen Bajorath
Journal:  J Exp Med       Date:  2002-04-15       Impact factor: 14.307

6.  ICOS deficiency hampers the homeostasis, development and function of NK cells.

Authors:  María Montes-Casado; Gloria Ojeda; Laura Aragoneses-Fenoll; Daniel López; Belén de Andrés; María Luisa Gaspar; Umberto Dianzani; José M Rojo; Pilar Portolés
Journal:  PLoS One       Date:  2019-07-08       Impact factor: 3.240

7.  Specific transcriptional programs differentiate ICOS from CD28 costimulatory signaling in human Naïve CD4+ T cells.

Authors:  Casimiro Luca Gigliotti; Elena Boggio; Francesco Favero; Danny Incarnato; Claudio Santoro; Salvatore Oliviero; Josè Maria Rojo; Silvia Zucchelli; Francesca Persichetti; Gianluca Baldanzi; Umberto Dianzani; Davide Corà
Journal:  Front Immunol       Date:  2022-09-05       Impact factor: 8.786

8.  Development, alteration and real time dynamics of conjunctiva-associated lymphoid tissue.

Authors:  Sebastian Siebelmann; Uta Gehlsen; Gereon Hüttmann; Norbert Koop; Torsten Bölke; Andreas Gebert; Michael E Stern; Jerry Y Niederkorn; Philipp Steven
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

Review 9.  Osteopontin at the Crossroads of Inflammation and Tumor Progression.

Authors:  Luigi Mario Castello; Davide Raineri; Livia Salmi; Nausicaa Clemente; Rosanna Vaschetto; Marco Quaglia; Massimiliano Garzaro; Sergio Gentilli; Paolo Navalesi; Vincenzo Cantaluppi; Umberto Dianzani; Anna Aspesi; Annalisa Chiocchetti
Journal:  Mediators Inflamm       Date:  2017-07-09       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.